DOCSLIB.ORG

Readingsample

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Readingsample Intervertebral Disk Diseases Causes, Diagnosis, Treatment and Prophylaxis Bearbeitet von Jürgen Krämer, Juergen Kraemer 3. bearb. Aufl. 2008. Buch. 365 S. Hardcover ISBN 978 3 13 582403 1 Format (B x L): 17 x 24 cm Weitere Fachgebiete > Medizin > Sonstige Medizinische Fachgebiete > Orthopädie, konservativ schnell und portofrei erhältlich bei Die Online-Fachbuchhandlung beck-shop.de ist spezialisiert auf Fachbücher, insbesondere Recht, Steuern und Wirtschaft. Im Sortiment finden Sie alle Medien (Bücher, Zeitschriften, CDs, eBooks, etc.) aller Verlage. Ergänzt wird das Programm durch Services wie Neuerscheinungsdienst oder Zusammenstellungen von Büchern zu Sonderpreisen. Der Shop führt mehr als 8 Millionen Produkte. References Abbasi A, Malhotra G, Malanga G, Elovic E, Kahn S. Complications of interlaminar cervical epidural steroid injections. Spine. 2007;32:2144–51. Abel R, Gerner H, Marisz G. Wirbelsäule und Rückenmark. Berlin: Blackwell; 1998. Abott KH, Retter RH. Protrusions of thoracic intervertebral discs. Neurology (Minneap.). 1956;6:1. Adams KM, Heilbronn M, Blumer D. A multimethod evaluation of the MMPI in a chronic pain patient sample. J. Clin.Psychol. 1986;42:878–86. Adams MA, Bogduk N, Burton K, Dolan P. The biomechanics of back pain. Philadelphia: Churchill Livingstone; 2004. Adams MA, Dolan P, Hutton WC, Porter RW. Diurnal changes in spinal mechanics. Kyoto: ISSLS Meeting; 1989 (Abstracts). Adams MA, Hutton WC. The effect of posture on diffusion into the lumbar intervertebral discs. Montreal: ISSLS Meeting; 1984 (Abstracts). Adson AW, Ott WO. Results of the removal of tumors ofthe spinal cord. Arch. Neurol. Psychiat. 1922;8:520. Aelart H. Porto: ISSLS Meeting; 2004 (Abstracts). Agency for health 1994. S. Arzneimittelkommission 2000. Agre K. Chymodiactin postmarketing surveillance. Spine. 1984;9:479. Ahn N et al. Does preoperative discography affect postoperative outcomes after lumbar interbody fusion for mechanical low back pain? A metaanalysis of the literature. Bergen: ISSLS; 2006 (Abstract 6). Ahn V, Ahn N, Kostnik J. Cauda-Equina-Syndrome secundary to lumbar disc herniation: Metaanalysis. Spine. 2000;25:1515–22. Aihara T, Takahashi K et al. Intervertebral disc degeneration associated with lumbosacral transitional vertebrae. J Bone Joint Surg Br. 2005;87:687–91. Airaksinen O, Brox JI, Cedraschi C et al. Chapter 4. European guidelines for the management of chronic non-specific low back pain. ESJ. 2006;15:192–300. Aita I, Hayashi K, Wadano Y, Yabuki T. Posterior movement and enlargement of the spinal cord after cervical laminoplasty. J Bone Joint Surg Br. 1998;80:33–37. Akerblom B. Standing and Sitting Posture. Stockholm: Nordiska Bokhandeln; 1948. van Akkerveeken P. Lateral Stenosis of Lumbar Spine. Utrecht: Libertas; 1989. van Akkerveeken P. On pain patterns of patients with lumbar nerve root entrapment. Neuroorthopaedics. 1993a;1481–102. van Akkerveeken P. Pain Pattern and Diagnostic Blocks. In Weinstein J, Wiesel S. The Lumbar Spine. Philadelphia: Saunders; 1990. van Akkerveeken P. The diagnostic value of nerve root sheath infiltration. Acta Orthop Scand. 1993b;251(Suppl.):61–3. van Akkerveeken, P. The fate of free fat graft. Montreal: ISSLS Meeting; 1984 (Abstracts). Alajonanine T, Thurel R. Lombo-sciatique par hernie discale et anomalies vertebrales. Rev. neurol. 1949;79:369. Albee FH. Transplantation of a portion of the tibia into thespine for Pott’s disease. J. Amer. med. Ass. 1911;547:885. Albers H. Zur Effektivität der paravertebralen Injektion nach Reischauer. Diss., Düsseldorf 1974. Albert H, Hauge E, Sorensen J, Donelson R, Manniche C. Centralization in patients with severe sciatica, type of centralization correlated with short-term prognosis and MRI-Findings. Abstr. 389. Porto: ISSLS; 2004:745. Albert H, Manniche C. Modic changes the prevalence and relationship to lumbar disc herniation. A possibel new pathogenesis of low back pain. Eur Spine J. 2005;14:4. Alcoff J et al. Controlled trial of imipramine for chronic low back pain. J. Fam Pract.. 1982;14:841–6. Alfidi RJ, Haaga J, Meaney TF. Computed tomography of the thorax and abdomen; a preliminary report. Radiology. 1975;117:257. Allan L, Richarz U, Simpson K, Slappendel R. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain. Spine. 2005;30:2484–90. Altenstein, G. Discographie am Hals und Lendenwirbelsäule. Z. Orthop. 1967;102:357. Alther E: Punktion des Wirbelkörpers zur Probeexcision. Zbl. Chir. 1957;82:1160. From Jürgen Krämer: Intervertebral Disk Diseases [ISBN 978-3-13-582403-1] © 2008 Georg Thieme Verlag KG, Stuttgart · New York Page 1 of 77 Ambrose J. Computerized transverse axial scanning (tomography). Part 2: Clinical application. Brit. J. Radiol. 1973;46:1023. Amis ES et al. American College of Radiology white paper on radiation dose in medicine. 2007;4:272–84. Amman J. Die gezielte Extensionsbehandlung der lumbalen Discopathie nach Ulrich. Med. Techn. 1955;8:24. Amundsen P, Skalpe JO: Cervial myelography with a water-soluble contrast medium (metrizamide). Neuroradiology.1975;8:209–12. An HS, Anderson PA, Haughton VM et al. Introduction. Disc degeneration: Summary. Spine. 2004;29:2677–8. An HS, Boden SD, Kang J, Sandhu HS, Abdu W, Weinstein J. Summary statement: Emerging techniques for treatment of degenerative lumbar disc disease. Spine. 2003;28(Suppl.):S24–5. An HS, Masuda K. Relevance of in vitro and in vivo models for intervertebral disc degeneration. JBJS. 2006;88-A:88–94. Anderson DG, Albert TJ, Fraser JK et al. Cellular therapy for disc degeneration. Spine. 2005;30(Suppl.):S14–19. Anderson DG, Vaccaro A, Gavin K. Cervical orthoses and cranioskeletal traction. In: Benzel EC, Currier BL, Clark CR, eds. The Cervical Spine: The Cervical Spine Research Society Editorial Committee. 4th ed. Philadelphia: Lippincott; 2005:110–21. Anderson G. Back pain and occupation. In Jayson M. The Lumbar Spine and Backpain. London: Pitman; 1985. Anderson G. The psychological challenges of disablingchronic back pain. Kyoto: ISSLS Meeting; 1989 (Abstracts). Anderson PA, Rouleau JP. Intervertebral disc arthroplasty. Spine. 2004;29:2779–86. Anderson u. Mitarb. 1987. In: Jerosch J, Steinleitner W, eds. Minimalinvasive Wirbelsäulenintervention. Köln: Deutscher Ärzteverlag; 2005. Andersson G, Deyo R. Sensitivity, specificity and predictive value: A general issue in screening for disease and in interpretation of diagnostic studies in spinal disorders. In: Frymoyer J, ed. The Adult spine: Principles and Practice. 2nd ed. New York: Raven Press; 1996. Andersson G, Jonsson B, Örtengren R. Myoelectric activity in individual lumbar erector spinae muscles in sitting – A study with surface and wire Electrodes. Scand J Rehab Med. 1974;3:91–108. Andersson G, McNeill TW. Lumbar Spine Syndromes. Berlin: Springer; 1989. Andersson G, Örtengren R, Nachemson A, Elfström G. Lumbar disc pressure and myoelectric back muscle activity. Scand. J. rehab. Med. 1974;6:128. Andersson G. Intradiscal electrothermal therapy. In: Szpalski M, Gunzburg R, eds. The Failed Spine. Philadelphia: Lippincott Williams; 2004: 163–8. Andersson G. Physiologic aging of the intervertebral disc and herniation in the adult. In: Gunzburg R, Szpalski M, eds. Lumbar disc herniation. Philadelphia: Lippincott Williams; 2002:65–71. Andersson G. Quantitative studies of back loads in lifting. Spine. 1976;1:178. Andersson G. The epidemiology of spinal disorders. In Frymoyer JW et al. The adult apine, principles and practice. New York: Raven; 1991, 107–46. Andrew J. Sacralisation: an aetiological factor in lumbar intervertebral disk lesions, and a cause of misleading focalsigns. Brit. J. Surg. 1954;42:304. Aneson K, Mosdal K, Vaernetf K. Percutaneous radiofrequency facet denervation in low back and extremity pain. Acta Neurochirurg. 1987;87:48–51. arbeitsmedizinischen Tauglichkeits-Screening-Untersuchung der ausgewählten Tätigkeiten. Z.ges. Hyg. 1980;26:181–7. Arct WA. Überlastungssyndrome als Vorbedingung für das Entstehen der Degeneration der Lenden- Kreuzbeinregion. Orthop. Traumatol. 1970;17:648. Arendt Y, Schorling S, Scale D, Schmitt C, Kurth A. Erfahrungen mit lumbalen Bandscheibenvorfällen bei Jugendlichen. Z Orthop. 2002;140:644–51. Armon C et al. Assessment: Use of epidural steroid injections to treat radicular lumbosacral pain: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2007;68:723–29. Armstrong J. Lumbar disc lesions. Baltimore: Williams & Wilkins; 1965. Arnold M. Histochemie. Berlin: Springer; 1968. Aronoff GM, Evans WO. Evaluation and treatment of chronic pain at the Boston Pain Center. J. Clin. Psychiat. 1982;4:4–9. From Jürgen Krämer: Intervertebral Disk Diseases [ISBN 978-3-13-582403-1] © 2008 Georg Thieme Verlag KG, Stuttgart · New York Page 2 of 77 Arseni C, Nash F. Thoracic intervertebral disc protrusion.J. Neurosurg. 1960;17:418. Arzneimittelkommission der Deutschen Ärzteschaft: Handlungsleitlinie Kreuzschmerzen. Aus: Empfehlungen zur Therapie von Kreuzschmerzen. Arzneimittelverordnung in der Praxis, 3. Aufl. 2007; ISSN 0930- 2017. Ascher PW. Intrathekale Cortisonbehandlung bei lumbalen Rhiozpathien. Zbl. Chir. 1969;94:1678. Assendelft W, Bouter L, Knipschild P. Complications of spinal manipulation: A comprehensive review of the literature. J Fam Pract. 1996;42:475–80. Assheuer J. 2002. s. Assheuer J. Magnetic resonance imaging examination for degenerative disease of the lumbar spine. In: Gunzburg R, Szpalski M, eds. Lumbar disc herniation. Philadelphia:
Load more

Recommended publications
  • Index to the NLM Classification 2011
    National Library of Medicine Classification 2011 Index Disease see Tyrosinemias 1-8 5,12-diHETE see Leukotriene B4 1,2-Benzopyrones see Coumarins 5,12-HETE see Leukotriene B4 1,2-Dibromoethane see Ethylene Dibromide 5-HT see Serotonin 1,8-Dihydroxy-9-anthrone see Anthralin 5-HT Antagonists see Serotonin Antagonists 1-Oxacephalosporin see Moxalactam 5-Hydroxytryptamine see Serotonin 1-Propanol 5-Hydroxytryptamine Antagonists see Serotonin Organic chemistry QD 305.A4 Antagonists Pharmacology QV 82 6-Mercaptopurine QV 269 1-Sar-8-Ala Angiotensin II see Saralasin 7S RNA see RNA, Small Nuclear 1-Sarcosine-8-Alanine Angiotensin II see Saralasin 8-Hydroxyquinoline see Oxyquinoline 13-cis-Retinoic Acid see Isotretinoin 8-Methoxypsoralen see Methoxsalen 15th Century History see History, 15th Century 8-Quinolinol see Oxyquinoline 16th Century History see History, 16th Century 17 beta-Estradiol see Estradiol 17-Ketosteroids WK 755 A 17-Oxosteroids see 17-Ketosteroids A Fibers see Nerve Fibers, Myelinated 17th Century History see History, 17th Century Aardvarks see Xenarthra 18th Century History see History, 18th Century Abate see Temefos 19th Century History see History, 19th Century Abattoirs WA 707 2',3'-Cyclic-Nucleotide Phosphodiesterases QU 136 Abbreviations 2,4-D see 2,4-Dichlorophenoxyacetic Acid Chemistry QD 7 2,4-Dichlorophenoxyacetic Acid General P 365-365.5 Organic chemistry QD 341.A2 Library symbols (U.S.) Z 881 2',5'-Oligoadenylate Polymerase see Medical W 13 2',5'-Oligoadenylate Synthetase By specialties (Form number 13 in any NLM
    [Show full text]
  • Abstract Book
    AEPROMO, 2012 Revista Española de Ozonoterapia Vol.2 No. 2. Supplement 1, 2012, ISSN 2174‐3215 III International Congress of AEPROMO "The ozonetherapy in the medical agenda" Spanish Association of Medical Professionals in Ozone Therapy III International Congress of AEPROMO 7th -9th June, 2012. Complutense University of Madrid, Spain. Abstract Book Abstract Book 7th - 9th June, 2012. Complutense University of Madrid, Spain. Organizer: Spanish Association of Medical Professionals in Ozone Therapy (AEPROMO) Page 1 of 117 AEPROMO, 2012 Revista Española de Ozonoterapia Vol.2 No. 2. Supplement 1, 2012, ISSN 2174‐3215 III International Congress of AEPROMO "The ozonetherapy in the medical agenda" Spanish Association of Medical Professionals in Ozone Therapy Index Scientific Committee ......................................................................................................................................................................... 4 Organizing committee....................................................................................................................................................................... 4 Sponsors........................................................................................................................................................................................... 5 Preface.............................................................................................................................................................................................. 8 Conference Agenda
    [Show full text]
  • Abstract Book 10Th -12Th November, 2011 Hotel Great Parnasuss, Cancun, Mexico
    AMOZON, 2011 Revista Española de Ozonoterapia Vol.2 Supplement 1 2012, ISSN 2174-3215 II International Medical Ozone Federation Congress. IMEOF III Mexican Ozonetherapy Association Congress. AMOZON "For the Integration of Ozonetherapy into the Conventional Medicine” II International Medical Ozone Federation Congress. IMEOF III Mexican Ozonetherapy Association Congress. AMOZON "For the Integration of Ozonetherapy into the Conventional Medicine” AAbbssttrraacctt BBooookk Abstract Book 10th -12th November, 2011 Hotel Great Parnasuss, Cancun, Mexico Organizer: Mexican Ozonetherapy Association (AMOZON) Page 1 of 121 AMOZON, 2011 Revista Española de Ozonoterapia Vol.2 Supplement 1 2012, ISSN 2174-3215 II International Medical Ozone Federation Congress. IMEOF III Mexican Ozonetherapy Association Congress. AMOZON "For the Integration of Ozonetherapy into the Conventional Medicine” Index Scientific committee ....................................................................................................................................................... 4 Organizing committee .................................................................................................................................................... 4 Sponsors ........................................................................................................................................................................ 5 Preface ..........................................................................................................................................................................
    [Show full text]
  • Abstract Book
    AEPROMO, 2017 Revista Española de Ozonoterapia Vol.7 No. 2. Supplement 1, 2017, ISSN 2174-3215 V International Congress of AEPROMO. VI International Congress of IMEOF “Better Ozone Therapy with Training, Investigation and Publication” Spanish Association of Medical Professionals in Ozone Therapy V International Congress of AEPROMO VI International Congress of IMEOF 1th -3th June, 2017. School of Medicine. Complutense University, Moncloa Campus, Madrid, Spain. Abstract Book Abstract Book 1th - 3th June, 2017. School of Medicine, Complutense University, Madrid, Spain. Organizer: Spanish Association of Medical Professionals in Ozone Therapy (AEPROMO) Page 1 of 96 AEPROMO, 2017 Revista Española de Ozonoterapia Vol.7 No. 2. Supplement 1, 2017, ISSN 2174-3215 V International Congress of AEPROMO. VI International Congress of IMEOF “Better Ozone Therapy with Training, Investigation and Publication” Spanish Association of Medical Professionals in Ozone Therapy Index Scientific Committee ............................................................................................................................................................................. 4 Organizing committee ........................................................................................................................................................................... 4 Sponsors ................................................................................................................................................................................................
    [Show full text]
  • Most Cited Publications in Cervical Spine Surgery
    Most Cited Publications in Cervical Spine Surgery Yu Chao Lee, Francis Brooks, Simon Sandler, Yun-Hom Yau, Michael Selby and Brian Freeman Int J Spine Surg 2017, 11 (3) doi: https://doi.org/10.14444/4019 http://ijssurgery.com/content/11/3/19 This information is current as of October 2, 2021. Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://ijssurgery.com/alerts The International Journal ofDownloaded Spine Surgery from http://ijssurgery.com/ by guest on October 2, 2021 2397 Waterbury Circle, Suite 1, Aurora, IL 60504, Phone: +1-630-375-1432 © 2017 ISASS. All Rights Reserved. Most Cited Publications in Cervical Spine Surgery Yu Chao Lee, Francis Brooks, Simon Sandler, Yun-Hom Yau, Michael Selby, Brian Freeman Royal Adelaide Hospital, Adelaide, Australia Abstract Purpose The purpose of this study is to perform a citation analysis on the most frequently cited articles in the topic of cervi- cal spine surgery and report on the top 100 most cited publication in this topic. Methods We used the Thomson Reuters Web of Science to search citations of all articles from 1945 to 2015 relevant to cer- vical spine surgery and ranked them according to the number of citations. The 100 most cited articles that matched the search criteria were further analyzed by number of citations, first author, journal, year of publication, country and institution of origin. Results The top 100 cited articles in the topic of cervical spine surgery were published from 1952-2011. The number of ci- tations ranged from 106 times for the 100th paper to 1206 times for the top paper.
    [Show full text]
  • Cervical Spine Considerations When Anesthetizing Patients with Down Syndrome Tara Hata, M.D.,* Michael M
    Ⅵ CLINICAL CONCEPTS AND COMMENTARY Richard B. Weiskopf, M.D., Editor Anesthesiology 2005; 102:680–5 © 2005 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Cervical Spine Considerations When Anesthetizing Patients with Down Syndrome Tara Hata, M.D.,* Michael M. Todd, M.D.† DOWN syndrome (DS) is the most common chromo- sion from the body of the vertebra. The dens passes somal disorder, occurring in 1 of every 600–800 births.1 cephalad immediately behind the anterior arch C1 and is It is characterized by mental retardation, as well as held in place by three ligaments (fig. 1). The transverse craniofacial, upper airway, cardiovascular, and gastroin- ligament (or the transverse component of the cruciate testinal anomalies. One manifestation of DS relevant to ligament) passes from side to side behind the odontoid anesthesiologists is upper cervical spine instability pro- and is anchored to the inside of the C1 ring. The atlan- duced by ligamentous laxity, skeletal anomalies, or both. todental ligament bridges the small space between the This instability can result in neurologic impairment, in- anterior aspect of the odontoid and the posterior aspect cluding quadriplegia. However, there are no evidence- of the anterior arch of C1 (this space is referred to as the based practical guidelines to aid anesthesiologists in car- anterior atlantodental interval [AADI]). The alar liga- ing for these patients. The risk of spinal cord injury ments extend from the dens upward and laterally to the during anesthesia is unknown, as are the preoperative occipital condyles, and the apical ligament extends from factors that might aid in accurately defining the risk in the tip of dens upward to the anterior margin of the specific patients.
    [Show full text]
  • Thoracic Outlet Syndrome Medical Treatment Guidelines
    RULE 17, EXHIBIT 3 Thoracic Outlet Syndrome Medical Treatment Guidelines Adopted: December 8, 2014 Effective: February 1, 2015 Adopted: January 9, 1995 Effective: March 2, 1995 Revised: January 8, 1998 Effective: March 15, 1998 Revised: September 29, 2005 Effective: January 1, 2006 Revised: September 12, 2008 Effective: November 1, 2008 Presented by: DIVISION OF WORKERS' COMPENSATION TABLE OF CONTENTS SECTION DESCRIPTION PAGE A. INTRODUCTION .............................................................................................................................. 1 B. GENERAL GUIDELINES PRINCIPLES .......................................................................................... 2 1. APPLICATION OF GUIDELINES ....................................................................................... 2 2. EDUCATION ....................................................................................................................... 2 3. INFORMED DECISION MAKING ....................................................................................... 2 4. TREATMENT PARAMETER DURATION ........................................................................... 2 5. ACTIVE INTERVENTIONS ................................................................................................. 2 6. ACTIVE THERAPEUTIC EXERCISE PROGRAM .............................................................. 3 7. POSITIVE PATIENT RESPONSE ...................................................................................... 3 8. RE-EVALUATE TREATMENT EVERY
    [Show full text]
  • Carpal Tunnel Syndrome, Humeral Epicondylitis, and the Cervical Spine
    BRITISH MEDICAL JOURNAL 12 JUNE 1976 1439 Discussion 1879.8 If there is clear evidence of clinical deterioration or there are focal neurological signs or there is a fractured skull, then One of the main aims in the management of head injuries is traumatic Br Med J: first published as 10.1136/bmj.1.6023.1439 on 12 June 1976. Downloaded from to ensure that complications are intracranial haematoma must be excluded before the prevented or, if this is not clinical state is ascribed to alcohol. In a patient who has taken possible, recognised soon enough to institute effective treat- alcohol and is in coma without focal ment. Even with reasonably prompt operations only a propor- signs or fracture some help of may be obtained from estimating the blood alcohol concentra- tion intracranial haematomas may be successfully treated, but tion; if it is under 43-4 this study indicates that when the operation is substantially mmol/l (200 mg/100 ml) altered con- delayed after clinical sciousness is unlikely to be due to alcohol alone.9 Whether a signs have been detected the mortalitv is traumatic intracranial haematoma is present, however, can be increased. Indeed, in this series several intracranial haematrsmas resolved were first discovered at necropsy. only by further investigation. The In the patient suspected of having had a cerebrovascular commonest reason for failing to recognise an intracranial accident the detection of a fractured skull haematoma is mistakenly attributing the depressed conscious is the best clue to to a management. All but four of the 33 patients with traumatic level cerebrovascular accident or excess alcohol.
    [Show full text]
  • 2020 Declaración-De-Madrid EN-7.Pdf
    MADRID DECLARATION ON OZONE THERAPY (3rd edition) Official document of ISCO3 EDITION No. 01 ISSUE DATE: June 4th, 2010 EDITION No. 02 ISSUE DATE: June 12th, 2015 EDITION No. 03 ISSUE DATE: May 14th, 2020 Copyright (©) 2010, 2015, 2020. ISCO3 (International Scientific Committee of Ozone Therapy) Avenida Juan Andrés 60, local 1 bajo, 28035, Madrid (Spain). All rights reserved. www.isco3.org [email protected] Tel. + 34 91 351 51 75 / +34 669 685 429 ISBN: 978-84-09-19932-7 Statutory Deposit: M-11427-2020 Original language: English. Reviewers: Adriana Schwartz, M.D. Gregorio Martínez Sánchez, Pharm. Dr., Ph.D. Cum Laude. Roberto Quintero, Lawyer Revision of English style: Wayne McCarthy and other members of ISCO3. The only official version of the Madrid Declaration on Ozone Therapy (ISCO3, 3rd edition, 2020) is published in English. Graphic design: Clara Barrachina. Secretarial support: Olga Moreno. Layout and printed by Grafox Imprenta, S.L. (Spain). International Scientific Committee of Ozone Therapy (3rd ed., 2020) “For the Unification of Criteria in the Practice of Ozone Therapy” Official document of ISCO3 1st edition: Approved at the “International Meeting of Ozone Therapy Schools” held at the Royal National Academy of Medicine in Madrid on June 4th, 2010, under the auspices of AEPROMO (Spanish Association of Medical Professionals in Ozone Therapy). 2nd edition with updates and addendum on Dentistry: Approved by ISCO3 on May 10th, 2015 and officially presented at the “International Meeting of the Madrid Declaration on Ozone Therapy (2nd ed.)” held at the Spanish Royal National Academy of Medicine in Madrid on June 12th, 2015, under the auspices of ISCO3 (International Scientific Committee of Ozone Therapy) and the administrative and logistical support of AEPROMO (Spanish Association of Medical Professionals in Ozone Therapy).
    [Show full text]
  • Alberto Alexandre Editor INTRODUCTION
    THE USE OF OZONE IN SPINAL DEGENERATIVE PATHOLOGIES Alberto Alexandre Editor INTRODUCTION Ozone is a very important gas in the stratosphere, reaching its maximum concentration (1000μg/m3above) at a height of 20-30km. Is an unstable gas. It is composed of three atoms of oxygen and has a high breakdown rate ranging in the order of 105-106mol/s. Ozone is 1.6 times denser and 10 times more soluble in water (49.0mLin 100mL of water at 0°C) than oxygen and even though ozone is not a radical molecule, it is the third most powerful oxidant after fluorine and perisulfate. Ozone is produced by three main sources of energy: chemical electrolysis, electrical shock, and UV radiation. Ozone-theraphy has been used for therapeutic purposes since the late XVII century, in different therapeutic modalities with unexpected results in some pathologies. In the scientific literature the first mention of ozone was by the Dutch physicist Van Marumom Mak in 1785. During experiments with a powerful facility for electrification he discovered that in the air around the “ Large lectic Machine” there was a gaseous substance with characteristic smell, which had strong oxidizing properties. In 1840 the professor of the University of Basel Christian Frederick Schonbein related the changes in the properties of oxygen with the formation of a particular gas which he called ozone (from the Greek word ozein “smelly”). Schonbein first detected ozone capacity to merge with biological substrates at positions corresponding to the double bonds. The German chemist Christian Friedrich Schonbein, is also known for the discovery of nitrocellulose.
    [Show full text]
  • Spinal Cord Injury Secondary to Cervical Disc Herniation in Ambulatory Patients with Cerebral Palsy
    Spinal Cord (1998) 36, 288 ± 292 1998 International Medical Society of Paraplegia All rights reserved 1362 ± 4393/98 $12.00 http://www.stockton-press.co.uk/sc Spinal cord injury secondary to cervical disc herniation in ambulatory patients with cerebral palsy Hyun-Yoon Ko1 and Insun Park-Ko2 Department of Rehabilitation Medicine, 1Pusan National University Hospital, Pusan National University College of Medicine, and 2Inje University Pusan Paik Hospital, Pusan, Korea Early onset of degeneration of the cervical spine and instability due to sustained abnormal tonicity or abnormal movement of the neck are found in patients with cerebral palsy. An unexplained change or deterioration of neurological function in patients with cerebral palsy should merit the consideration of the possibility of cervical myelopathy due to early degeneration or instability of the cervical spine. We describe two patients who had a spinal cord injury due to a cervical disc herniation, one patient was athetoid and the second had spastic diplegia, they both had cerebral palsy. It is not easy to determine whether new neurological symptoms are as a result of the cervical spinal cord disorder. These cases suggest that consideration of a cervical spine disorder with myelopathy is required in the evaluation of patients with cerebral palsy who develop deterioration of neurological function or activities over a short period of time. Keywords: spinal cord injury; cerebral palsy; cervical disc herniation Introduction There is a small, but growing body of literature on the excessive compressive load on the dorsal aspect of the later-life complications of congenital or early-onset disc. The extended duration of this shearing force or acquired disabilities.1 Aging in patients with cerebral loading in the spine exerts an early degeneration of the palsy amongst those with neuromuscular disorders has corresponding cervical spine, with or without myelo- been extensively studied.
    [Show full text]
  • Artemis Health Tariff.Pdf
    Billing Sr No Procedure Type Codes Procedure Name Price 1 Ambulance Charges EMA001 Ambulance Base Charges(ACLS) 832 2 Ambulance Charges EMA002 Ambulance Rate(ACLS) 44 3 Ambulance Charges EMA003 Ambulance Waiting Time (after 1st hour) 1,556 4 Ambulance Charges EMA004 Doctors Charges Per hour after 2 hours 886 5 Ambulance Charges EMA005 Oxygen 303 6 Ambulance Charges EMA006 Monitor 303 7 Ambulance Charges EMA007 Ventilator 2,344 8 Ambulance Charges EMA008 Porta Vent (ER) 303 9 Ambulance Charges EMA010 TranscutaneousTemporaryCardiacPacing(Am) 1,426 10 Ambulance Charges EMA015 Splinting 1,556 11 Ambulance Charges EMA017 Foley Catheterization 638 12 Ambulance Charges EMA023 ASSISTED MANUAL VENTILATION(AMBULANCE) 918 13 Ambulance Charges EMA025 Consultant Charges Ambulance 1,556 14 Ambulance Charges EMA206 Ryles Tube Insertion 638 15 Ambulance Charges EMA021 Doctors charges (min 2 hrs) 1,394 16 Ambulance Charges EMA100 Ambulance Base Rate(BLS) 638 17 Ambulance Charges EMA101 Ambulance Rate(BLS) 33 18 Anesthesia ANZ112 Unstable patient management 6,264 19 Anesthesia ANZ113 ACT 141 20 Anesthesia ANZ114 FSBS 141 21 Anesthesia ANZ115 Epidural steroid injection 3,564 22 Anesthesia ANZ093 MD Anesthetist for Ambulance (4 hours) 3,564 23 Anesthesia ANZ094 MD Anesthetist for Ambulance (addl hour) 1,556 24 Anesthesia ANZ095 CODE BLUE 3,564 25 Anesthesia ANZ096 Stand by anaesthes for Diagnostics/other 994 26 Anesthesia ANZ098 GA for ECT 3,564 27 Anesthesia ANZ101 Anesthesia visit for emergency managemen 1,556 28 Anesthesia ANZ099 MAC (Sedation) for cath
    [Show full text]